Aug 01, 2016 - When, and if, Uber goes public, it will be an IPO like never before, and one that draws in the retail investor who is looking to cash in on a household name going public for the first time.
Aug 03, 2016 - On Tuesday, Instagram, the popular photo-sharing app, announced a new feature called "Stories" where users can post photo and video slideshows that disappear after a 24-hour period. This sounds shamelessly familiar to Snapchat Stories. Instagram isn't the only company copying Snapchat's platform, so what is it about Snapchat that makes it so compelling?
Mar 02, 2017 - Last year, Instagram, the popular photo-sharing app, announced a new feature called "Stories" where users can post photo and video slideshows that disappear after a 24-hour period. If you think that sounds a lot like Snapchat, you'd be correct: it's almost exactly like Snapchat.
Jul 22, 2016 - Facebook (FB) has come a long way since its inception in a dorm room at Harvard. With its Q2 Earnings Report right around the corner, let's take a look at why Facebook still has plenty of gas left in the tank.
Jul 06, 2017 - Will two of the biggest tech IPOs from 2016 finally impress investors this year?
Jul 15, 2016 - Every Friday afternoon Maddy Johnson and Ryan McQueeny discuss the week's biggest news, and Pokemon GO and Amazon Prime dominated the headlines.
Apr 26, 2017 - The Japanese messaging company's Q1 sales and earnings jumped -- but perhaps not quite high enough.
Mar 27, 2017 - Aurinia Pharmaceuticals (NASDAQ:AUPH) perks up 6% premarket on average volume in response to its announcement of positive results from an open-label study, AURION, assessing lead product can
Jul 18, 2016 - Spotify, the biggest name in streaming music industry, could be poised for a huge debut on the market after its latest $1 billion round of funding. Is the company the next big IPO candidate of the year?
Jun 16, 2017 - Aurinia Pharmaceuticals (NASDAQ:AUPH) is up 5% premarket on average volume in response to its announcement of results from its Phase 2b AURA-LV study assessing voclosporin for the treatment